General Information of Drug Transporter (DT)
DT ID DTD0152 Transporter Info
Gene Name SLC22A9
Transporter Name Organic anion transporter 7
Gene ID
114571
UniProt ID
Q8IVM8
Post-Translational Modification of This DT
Overview of SLC22A9 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC22A9 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

39

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC22A9 Asparagine 39 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC22A9 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

56

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC22A9 Asparagine 56 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC22A9 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

102

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC22A9 Asparagine 102 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC22A9 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

81

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC22A9 Serine 81 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S22A9_HUMAN)
2 Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.